US health officials have authorised Eli Lilly’s COVID-19 treatment for a new use in preventing disease in people who have been recently exposed to the virus.
The Food and Drug Administration on Thursday granted emergency use of the drug for adults and children older than 12 who may have an infection and are at high-risk for getting severe COVID-19. Previously the drug was authorized for high-risk patients with confirmed COVID-19. Earlier this summer the FDA authorised preventative use for a similar antibody drug from competitor Regeneron Pharmaceuticals.
Antibody drugs are one of the only treatments proven to reduce the risk of death from COVID-19, especially for people who are not yet in the hospital. Demand for the drugs has boomed as the delta variant sends cases surging again across the U.S. Federal officials have reported a 20-fold increase in orders for the drugs since mid-July.
- Essential Eye-Care Tips For A Safe Diwali - October 27, 2021
- Mansukh Mandaviya to hold meeting with state health ministers - October 27, 2021
- COVID-19: Kerala logs 7,163 new cases, 482 deaths - October 27, 2021
- Govt plans to invest Rs 100 cr per district to upgrade healthcare infra - October 27, 2021
- COVID-19: Active cases drop to 74,735 in Kerala - October 26, 2021
- Ayushman Bharat Health Infrastructure Mission: Everything you must know about ‘India’s largest health infra scheme’ - October 26, 2021
- Moderna to supply Africa with up to 110 million COVID doses - October 26, 2021
- India committed to supplying COVID-19 vaccines to other nations - October 25, 2021
- Mamata Banerjee asks people to wear mask to prevent spike in Covid cases - October 25, 2021
- Dengue cases in Delhi cross 1,000-mark; over 280 fresh cases in one week - October 25, 2021